L

Lord Cryer (Lab)

Speaking in the House of Lords on 18 November 2024

Debate

NHS: Anti-obesity Medication

Contribution

I am very grateful to the noble Lord. Of course, I will always give him the answers that he seeks. He touches on a lot of issues there—his question alone is probably worth a QSD. However, touching on one or two, the whole reason for the existence of NICE is to examine value for money for the taxpayer and effectiveness. Drugs are not approved and licensed simply for the sake of it, and certainly are not doled out by the NHS for the same reason. There is a range of measures in place. The weight-management services, which are available across the country, extend from the most basic end, using an NHS app, through a range of services and across a range of agencies through to surgery and the use of drugs. When he touches on the use of drugs by children, I think what he is talking about is not so much the drugs that are prescribed but children getting access potentially to the online world and getting online drugs that are not prescribed—which is a whole different issue.

More from Lord Cryer (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

Partner sites